Okay, let's tackle this question. The question is about when calcitonin isn't used. First, I need to remember the main uses of calcitonin. Calcitonin is a hormone that lowers blood calcium levels. It works by inhibiting osteoclasts, which are the cells that break down bone. So it's used in conditions where there's excessive bone resorption.

The options aren't provided, but common diseases related to calcitonin use include hypercalcemia, Paget's disease, osteoporosis, and maybe others. Let's think about each. Hypercalcemia is a clear indication because calcitonin lowers calcium. Paget's disease is also treated with calcitonin to reduce bone turnover. Osteoporosis might be another use, though bisphosphonates are more common.

Now, the question asks where calcitonin is NOT given. Hyperparathyroidism comes to mind. In primary hyperparathyroidism, the parathyroid glands are overactive, leading to high calcium. But calcitonin isn't the primary treatment here. Surgery to remove the parathyroid is the main treatment. Calcitonin might lower calcium temporarily, but it's not a long-term solution for hyperparathyroidism. So if one of the options is hyperparathyroidism, that's the answer.

Another possible wrong option could be hypoparathyroidism, but that's not the case. Hypoparathyroidism has low calcium, so you wouldn't use calcitonin there. But maybe the question is about hyperparathyroidism. Let me confirm. The key is that calcitonin isn't used in primary hyperparathyroidism because it's not addressing the underlying cause. The other options might include conditions where calcitonin is used, like hypercalcemia of malignancy or Paget's disease.

So the correct answer is primary hyperparathyroidism. The other options would be diseases where calcitonin is appropriate. The clinical pearl is that calcitonin is a symptomatic treatment for hypercalcemia but not a cure for hyperparathyroidism. Students should remember that the mainstay for hyperparathyroidism is surgery, not calcitonin.

**Core Concept**
Calcitonin inhibits osteoclast-mediated bone resorption and lowers serum calcium. It is used in hypercalcemia of malignancy, Paget's disease, and osteoporosis but **not** in primary hyperparathyroidism due to its inability to address the underlying parathyroid overactivity.

**Why the Correct Answer is Right**
In **primary hyperparathyroidism**, elevated parathyroid hormone (PTH) drives bone resorption and hypercalcemia. Calcitonin transiently lowers calcium by inhibiting osteoclasts but does not suppress PTH secretion or treat the parathyroid adenoma. Definitive therapy requires surgical removal of the overactive gland.

**Why Each Wrong Option is Incorrect**
**Option A:** *Hypercalcemia of malignancy* – Calcitonin is used here for rapid calcium reduction.
**Option B:** *Paget’s disease* – Calcitonin reduces bone turnover in this disorder.
**Option D:** *Osteoporosis* – Calcitonin is a second-line agent for postmenopausal osteoporosis.

**Clinical Pearl / High-Y

✓ Correct Answer: B. Thyrotoxicosis